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Abstract
The human apolipoprotein e4 allele (APOE4) has been implicated as one of the strongest genetic risk factors associated with
Alzheimer’s disease (AD) and in influencing normal cognitive functioning. Previous studies have demonstrated that mice
expressing human apoE4 display deficits in behavioral and neurophysiological outcomes compared to those with apoE3.
Ovarian hormones have also been shown to be important in modulating synaptic processes underlying cognitive function,
yet little is known about how their effects are influenced by apoE. In the current study, female adult human APOE targeted
replacement (TR) mice were utilized to examine the effects of human APOE genotype and long-term ovarian hormone loss
on synaptic plasticity in limbic regions by measuring dendritic spine density and electrophysiological function. No
significant genotype differences were observed on any outcomes within intact mice. However, there was a significant main
effect of genotype on total spine density in apical dendrites in the hippocampus, with post-hoc t-tests revealing a
significant reduction in spine density in apoE3 ovariectomized (OVX) mice compared to sham operated mice. There was also
a significant main effect of OVX on the magnitude of LTP, with post-hoc t-tests revealing a decrease in apoE3 OVX mice
relative to sham. In contrast, apoE4 OVX mice showed increased synaptic activity relative to sham. In the lateral amygdala,
there was a significant increase in total spine density in apoE4 OVX mice relative to sham. This increase in spine density was
consistent with a significant increase in spontaneous excitatory activity in apoE4 OVX mice. These findings suggest that
ovarian hormones differentially modulate synaptic integrity in an apoE-dependent manner within brain regions that are
susceptible to neurophysiological dysfunction associated with AD.
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Introduction
Alzheimer’s disease (AD) is a cognitive disorder that causes
progressive loss of memory and intellectual abilities. It is the most
common cause of dementia in individuals over the age of 60.
Although both men and women are at risk, sexual dimorphisms in
the progression of AD have been shown where women have a
greater prevalence and up to a three times greater risk for
developing the disease than men [1–3].
Genetic risk factors have also been associated with development
of late onset and sporadic Alzheimer’s disease. Of the three
possible human alleles of the APOE gene (e2, e3 and e4), the e4
allele encodes for a protein that is associated with increased risk of
the disease [4,5]. This cholesterol and lipid transport protein is
known to play a critical role in brain development by modulating
neuronal growth, maintenance, repair, and protection [6]. In
comparison to individuals lacking the e4 allele, risk of AD
increases 3-fold with one allele and 12-fold with two alleles [7].
Conversely, the e2 allele is associated with a lower risk [8].
Furthermore, studies have also shown a stronger association with
the e4 allele for AD in women [9,10].
Cognitive decline in AD is often associated with progressive loss
of neuronal function, a process that is largely dependent on
dendritic spines. Through predominantly excitatory connections,
they are responsible for regulating synaptic strength and they are
important in maintaining memory throughout the lifespan.
Several studies have demonstrated that apoE4 exerts neuropath-
ological effects through changes in dendritic spine morphology.
For example, apoE4 transgenic mice and apoE4 AD patients both
showed reduced spine density in the dentate gyrus of the
hippocampus as compared to the apoE3 genotype [11]. Other
studies using male human APOE targeted replacement (TR) mice
showed reduced spine density in layer II/III cortical neurons at 1,
3, and 12 months of age in apoE4 compared to apoE3 mice, but
no differences in the CA1 or dentate gyrus regions of the
hippocampus [12]. A more recent study showed a reduction in
spine density in CA1 hippocampus and entorhinal cortex from
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aged (19–21 months), but not adult (7–8 months), female apoE4
TR mice [13]. Taken together, these studies indicate that sex,
brain region and the cellular source of apoE are important factors
regarding the apoE isoform specific effects on spine morphology.
Structural and functional synaptic plasticity is also highly
regulated by ovarian hormones. For example, dendritic spine
density is increased by estradiol treatment in cultured hippocam-
pal neurons [14,15]. It has also been demonstrated that spine
density fluctuates across the estrous cycle [16] and ovariectomy
induces a decrease in spine density in adult female rats [17].
Electrophysiological studies also show a similar effect of estrous
cycle on the magnitude of LTP [18,19]. Similarly, other authors
have shown that the effects of estrogen on NMDA glutamate
receptors have been related to the formation of new spines, which
could explain the tendency to see an increased number of spines
during proestrus, when estrogen levels are highest, in rodents [20].
The beneficial effects of estradiol have also been shown to be
dependent upon apoE. For example, estradiol enhanced neuronal
outgrowth and synaptic sprouting in wild-type mice, but not in the
presence of apoE4 of in apoE knock-out mice [21–23]. Other
studies have shown regionally-specific changes in apoE expression
by estradiol treatment that is also dependent on estrogen receptor
subtypes [24,25]. This complex interaction between apoE and
estrogen is a likely contributor to the confounding effects of
hormone replacement therapy where some studies have shown
beneficial effects [26,27] while others have not [28,29].
The amygdala is also impacted by AD, and atrophy in this
region is comparable to hippocampal atrophy in early stages of the
disease [30]. Furthermore, emotional event memory has been
more highly correlated to amygdalar damage than hippocampal
volume [31]. Therefore, anxiety and emotional symptoms
associated with AD are likely the result of changes in this brain
region. Despite this implication, relatively few studies have
investigated the role of apoE in synaptic changes in the amygdala.
One study demonstrated that apoE4 TR mice have decreased
synaptic integrity in the amygdala at 6 months of age [32]; these
deficits manifest as early as one month of age, and the presence of
apoE2 attenuates the effects of apoE4 [33]. In patients with
Alzheimer’s disease, individuals homozygous for the e4 allele
showed greater atrophy in the amygdala compared to patients
either lacking the e4 allele or those with one e4 allele [34,35]. It is
currently unknown how apoE influences spine morphology and
physiology within this region in females.
The aim of the current study was to utilize a relevant mouse
model to assess the effects of human APOE genotype and loss of
circulating ovarian hormones on spine density and electrophysi-
ological activity in the hippocampus and amygdala to test the
hypothesis that ovarian hormones are protective against apoE4-
associated deficits. We predicted that the presence of estrogen in
cycling females would be protective against any genotype
differences within intact mice but that ovariectomy would
adversely affect synaptic integrity in both genotypes with deficits
being significantly more severe in apoE4 mice than apoE3 mice.
Given the reported complexities associated with hormone
replacement therapy, particularly on the basis of APOE genotype,
understanding how apoE and the hormonal milieu interact to
influence synaptic integrity in females is critical to developing




All animal procedures performed in this study were approved by
the Durham VA Medical Center Animal Care and Use
Committee (protocol number ACUC 1631-001).
Animals
The APOE TR mice used in this study were generated by gene
targeting as described previously [13,36]. Briefly, the TR mice
contain human APOE genomic fragments in the mouse Apoe gene
locus via homologous recombination and are therefore under
endogenous regulation in a C57B16/J background. Both lines of
APOE TR mice contain chimeric genes consisting of mouse 59-
regulatory sequences continuous with mouse exon 1, followed by
human exons (and introns) 2–4. Thus, the TR mice regulate apoE
expression in the same fashion. Mice used in this study were
generated from separate breed pairs (that have been back-crossed
to C57B16/J mice 8 times and are therefore .99.6% C57B16/J)
for each genotype. All mice were maintained on a standard
laboratory rodent diet (LabDiet, St. Louis, MO).
Surgery
Sham or ovariectomy (OVX) surgery was performed at 5
months of age according to IACUC-approved Durham VA
Medical Center Animal Use Protocol. Briefly, mice were
continuously anesthetized using isoflurane gas and a subcutaneous
injection of buprenorphine (0.1 mg/kg) and carprofen (4 mg/kg)
was administered as an analgesic and anti-inflammatory. The
lower back was shaved and sterilized and a single, small (,2 cm)
incision was made to expose the back muscles. A second incision
was made in the muscles above each of the ovaries. Each ovary
was pulled out through the incision and cut just above the uterus
and then the uterus was replaced. The muscle layer was closed
using absorbable suture. Local anesthesia was applied at the
incision and the skin was closed using sutures or surgical glue.
Mice were placed on a heating pad and allowed to recover and
then returned to their original cage and group-housed for the
remainder of the study.
Estrous cycle in females was monitored beginning one week
after surgery. Vaginal secretions were collected daily for 3 weeks
(4–5 days/cycle) in both intact and OVX female mice and
examined under a light microscope using a 10x objective. Vaginal
secretions in OVX mice had very few cells, confirming the
cessation of the estrous cycle.
Electrophysiology
Acute coronal slices (400 mm thick) were prepared from mice 4–
5 weeks post-surgery. Briefly, mice were anaesthetized with
isoflurane and decapitated. Brains were quickly removed and
placed in ice-cold oxygenated artificial cerebral spinal fluid (ACSF)
containing (in mM): 116.4 NaCl, 5.4 KCl, 1.6 MgSO4, 3.2 CaCl2,
1 NaH2PO4, 26.2 NaHCO3 and 10 glucose. The brain was glued
to the stage of a Vibratome 1000 Plus (Vibratome, Campden,
England) and immersed in ice-cold oxygenated ACSF. Slices were
transferred to a holding chamber and incubated for at least 1 hour
prior to electrophysiological analysis.
Whole-cell patch-clamp recordings were performed in lateral
amygdala neurons using patch pipettes with resistances of 3–5 MV
filled with an internal solution. For the recording of spontaneous
excitatory post-synaptic currents (sEPSCs) the internal solution
contained (in mM): 140 potassium gluconate, 0.5 CaCl2,
2 MgATP, 2 MgCl2, 5 EGTA, and 10 Hepes (pH 7.2–7.4). For
the recording of spontaneous inhibitory post-synaptic currents
Ovarian Hormone Loss in APOE TR Mice
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(sIPSCs) the internal solution contained (in mM): 140 CsCl,
2 MgCl2, 0.5 EGTA, 4 MgATP, 0.5 Tris GTP, 10 Hepes and 5
QX-314 (pH 7.2–7.3). Slices were superfused at room temperature
(22–25uC) with ACSF containing in mM: 126 NaCl, 2.5 KCl,
1.3 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 25 NaHCO3 and 10 glucose.
Neurons were clamped at –70 mV and recordings were made
using an Axopatch 200B amplifier, filtered at 1 kHz, and sampled
at 10 kHz using pClamp 10.1 software (Molecular Devices, LLC,
Sunnyvale, CA). The sEPSC and sIPSC intervals and amplitudes
were measured using Mini Analysis software (Synaptosoft, Inc.
Decatur, GA). Firing properties and electrical excitability were
measured using whole-cell current-clamp mode by applying
hyper- and depolarizing step pulses for 1 s durations ranging
from –0.2 to 0.2 nA in 25 pA increments.
Extracellular field recordings were performed in the CA1 area
of the hippocampus using modified techniques described previ-
ously [37]. Coronal hippocampus sections were maintained at
30uC in the recording chamber and perfused at flow rate of 4 mL/
min with the same ACSF solution that was used for preparing
brain slices. A glass micropipette recording tip (2 mm, 2–4 MV
containing 100 nM NaCl) was placed in the CA1 stratum
radiatum and field excitatory post-synaptic potentials (fEPSPs)
elicited by stimulating the Schaffer collateral fibers with a
concentric bipolar stimulating electrode were recorded using an
Axopatch 200B amplifier and pClamp software. For all experi-
ments, input/output curves were generated and the subsequent
baseline stimulus intensity was set at a level that elicited 40% of
maximal fEPSP response. Baseline was measured for 20 minutes
and long-term potentiation (LTP) was induced using a theta burst
stimulation protocol consisting of 2 trains of 10 bursts at a
frequency of 100 Hz with a 30 sec interval followed by a single
stimulus (as used in baseline recordings) every minute for a total of
60 minutes.
Golgi Staining and Analysis
Neurons were impregnated using the Rapid Golgi Stain Kit (FD
Neurotechnologies, Baltimore, MD) according to the package
protocol. Briefly, mice were anesthetized using isoflurane,
decapitated and the brains were quickly removed and immersed
in a 1:1 mixture of solutions A and B. After 2 weeks, the brains
were transferred to solution C for 48 hrs then removed and frozen
in tissue freezing medium (Electron Microscopy Sciences, Hatfield,
PA), cut into 100 mm thick coronal sections using a cryostat, and
mounted onto 2% gelatin coated slides (LabScientific, Inc.,
Livingston, NJ). Sections were stained with a mixture containing
solutions D and E, dehydrated in ethanol, cleared in xylene and
coverslipped with Permount. In cycling, sham-operated female
mice, brains were isolated during the proestrus phase of the estrous
cycle. Golgi-impregnated neurons were visualized using a
Neurolucida system and software (MBF Bioscience, Williston,
VT) and image stacks were generated using a 100X oil immersion
lens. Each image stack was extracted using Image J software
(available for free download at http://rsb.info.nih.gov/ij/index.
html) and subsequently imported into RECONSTRUCT software
[38] (available for free download at http://synapse.clm.utexas.
edu) for further analysis. Dendritic spine types were analyzed using
an unbiased rating system (developed by W.C. Risher, unpub-
lished) by measuring the length and width of each protrusion with
visible connections to the dendritic shaft. Spine densities were
determined on the secondary branches of pyramidal-like lateral
amygdala neurons and on the apical oblique and second and third
order basal dendrites of hippocampal CA1 pyramidal neurons.
Data were collected from dendritic segments approximately
10 mm in length and average spine densities were calculated using
two separate dendrites from at least 4–5 separate image stacks per
animal (N=4 mice/group). Spine types were determined on the
basis of the ratio of the width of the spine head to the length of the
spine neck and classified as filopodia, thin, mushroom and stubby.
Statistical Analysis
For comparison of morphological and electrophysiological end-
points a two-way ANOVA was performed using GraphPad Prism
software (GraphPad Software, Inc. La Jolla, CA) with genotype and
surgery status as independent variables. Because of the nature of the
hypotheses, we anticipated an ordinal interaction. That is, while we
expected ovariectomy to affect both apoE3 and apoE4 mice, we
hypothesized that apoE4 mice would be more affected than apoE3
mice. Given the well-described difficulty in detecting ordinal
interactions using ANOVA [39], analyses were followed by tests of
simple main effects using a student’s t-test. Statistical significance
was established at alpha ,0.05.
Results
Synaptic plasticity was examined in the within the CA1 region
of the hippocampus and the lateral amygdala in adult sham-
operated and ovariectomized (OVX) apoE3 and apoE4 TR
female mice to compare genotype differences and to determine if
the long-term loss of circulating sex hormones differentially
influence synaptic structure and function on the basis of apoE.
Females underwent surgery to remove the ovaries at 5 months of
age and brains were processed 4–5 weeks later. In sham-operated
females, analysis was performed at the proestrus stage of the
estrous cycle.
Effects of Ovarian Hormone Loss on CA1hippocampal
Spine Denisty and LTP in Female apoE TR Mice
Representative photomicrographs of CA1 pyramidal neurons
and plots of the average total spine density from apical and basal
dendrites are presented in Figure 1 and values are listed in Table 1.
A two-way ANVOA of total spine density resulted in a main effect
of genotype among apical dendrites (F1,102 = 5.678, p = .019), but
no effect of surgery. Simple main effects analysis revealed a
significant reduction in OVX E3 mice relative to sham E3 mice
(p = 0.0077). Conversely, there were no significant surgery effects
on total spine density among basal dendrites. In addition, there
was no effect of genotype among sham-operated mice on either
apical or basal dendrite spine density. Apical and basal dendrite
spine type densities were assessed and are presented in Table 1.
There were no significant genotype or surgery effects among these
spine types.
Basal synaptic transmission and long-term potentiation were
measured in order to assess the effects of genotype and surgery
status on functional activity within the CA1 region of the
hippocampus. Input-output (I/O) curves were generated by
measuring fEPSP slope in response to increasing stimulus intensity
and are presented in Figure 2. ApoE3 sham and OVX mice
showed comparable responses to increasing stimulus intensity,
whereas apoE4 OVX mice demonstrated an increase in fEPSP
slope relative to sham. A two-way ANOVA of the average I/O
slopes measured between 1 mA and 150 mA (Figure 2C) resulted in
a significant main effect of surgery (F1,39 = 8.647, p = 0.0055) with
simple main effects analysis revealing a significant increase in I/O
slope in apoE4 OVX mice relative to sham (p= 0.0033) but not in
apoE3 mice (p = 0.317).
Long-term potentiation was successfully induced within all of
the groups as shown in Figure 2D and 2E. A two-way ANOVA
comparing the average percent potentiation of the last 20 minutes
Ovarian Hormone Loss in APOE TR Mice
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Figure 1. Ovariectomy decreases CA1 apical dendrite spine density in female apoE3 TR mice. (A) Representative photomicrographs of
Golgi-stained CA1 pyramidal neurons from a female apoE3 TR mouse brain using a 2.5X and 20X objective. (B) Apical dendritic spines from the
designated cohorts using a 100X objective. Dendritic spines were analyzed on apical (square) and basal (circle) dendrites as indicated in the
demarcated regions. Scale bar in (B) is 5 mm. Average total spine density on apical (C) and basal (D) dendritic segments within CA1 pyramidal neurons
in female apoE TR mice. A two-way ANOVA revealed a significant interaction among the groups for apical spine density (F1,102 = 5.678, p,0.019) with
post-hoc t-tests showing significantly lower density in apoE3 OVX compared to apoE3 sham (p= 0.0077). There were no significant differences in total
basal dendrite spine density. Data represents the mean spine density6 SEM from 6–8 dendritic segments per mouse, with N= 4 mice for each group.
doi:10.1371/journal.pone.0094071.g001
Table 1. Total and spine-type density from hippocampal (Hpc) CA1 pyramidal neuron apical and basal dendrites and lateral
amygdala neurons in sham-operated and OVX apoE TR mice.
Region/Type E3 Sham E3 OVX E4 Sham E4 OVX
Hpc apical
Total Density 23.660.7 21.260.5* 24.060.9 24.060.6
Filopodia 2.060.3 1.660.3 2.060.5 1.760.3
Thin 12.060.8 10.460.8 12.760.8 11.660.8
Mushroom 8.160.7 7.560.7 7.060.5 8.360.7
Stubby 1.560.3 1.760.2 2.260.3 2.460.3
Hpc basal
Total Density 19.760.6 18.760.3 19.660.5 19.860.5
Filopodia 0.960.2 0.960.3 1.26.04 0.860.3
Thin 9.160.8 9.960.9 10.560.6 10.360.8
Mushroom 6.760.6 5.560.8 5.160.6 6.460.6
Stubby 2.560.4 2.460.4 2.860.4 2.460.3
Lateral amygdala
Total Density 18.360.6 18.260.5 18.260.5 20.460.6*
Filopodia 2.360.3 1.860.4 1.460.2 2.660.4*
Thin 10.560.7 9.960.7 10.060.6 12.460.6*
Mushroom 2.860.4 3.360.4 3.660.5 2.460.4**
Stubby 2.760.3 3.260.3 3.260.3 3.060.4
Spine density (spines/10 mm) is presented as mean 6 SEM, *p,0.001, **p,0.05 for OVX relative to sham within the same genotype.
doi:10.1371/journal.pone.0094071.t001
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of recording (Figure 2F) resulted in a main effect of surgery
(F1,38 = 8.038, p = 0.0073). Simple main effects analysis revealed a
significant reduction in LTP magnitude in apoE3 OVX mice
relative to apoE3 sham (p= 0.019). Although the trend was similar
among apoE4 mice (OVX,Sham), it was not significant
(p = 0.136). There were also no significant genotype differences
between sham-operated mice (p= 0.304).
Effects of Ovarian Hormone Loss on Lateral Amygdala
Spine Denisty and Neuronal Activity in Female apoE TR
Mice
Representative photomicrographs depicting pyramidal-like
neurons and dendritic spines in the lateral amygdala are illustrated
in Figure 3A and 3B. Plots of the average total spine density are
presented in Figure 3C and the values are listed in Table 1. A two-
way ANOVA resulted in a significant interaction on total spine
density (F1,105 = 4.740, p = .0317). Simple main effects analysis
revealed a significantly higher total spine density in apoE4 OVX
mice relative to sham (p= 0.0038). Similar to the hippocampus,
there were no significant genotype differences within sham-
operated mice. Spine type densities were also measured and the
values are preseneted in Table 1. There was a significant
interaction on measures of filopodia (F1,105 = 6.601, p = 0.012),
thin (F1,105 = 4.942, p = 0.028) and mushroom (F1,105 = 4.653,
p = 0.033) spine density. Simple main effects analysis revealed a
significant increase in filopdia (p = 0.0064) and thin (p= 0.0065)
spine density and a decrease in mushroom spine density
(p = 0.028) in apoE4 OVX mice compared to apoE4 shams.
There were no signficant differences in total or spine type densities
between apoE3 OVX and sham-operated mice.
Whole cell patch-clamp recordings were obtained from
pyramidal neurons within the lateral amygdala in order to assess
the effects of genotype and surgery status on functional activity
within this region. Spontaneous excitatory post-synaptic current
(sEPSC) and inhibitory post-synaptic current (sIPSC) amplitudes
and frequencies were measured from 2-minute continuous
recordings from 2–4 neurons from 6–8 mice per group.
Representative traces and comparison of genotype and surgery
status on the mean sEPSC and sIPSC amplitudes and frequencies
are presented in Figure 4A and 4B, respectively. A two-way
ANOVA of sEPSC frequencies resulted in a significant interaction
(F1,62 = 10.41, p = 0.002). Simple main effects analysis revealed a
significantly higher sEPSC frequency in apoE4 OVX mice relative
to sham apoE4 mice (p = 0.0004). There were no significant
genotype differences within sham-operated mice and there was no
significant effect of OVX in apoE3 females. There were no
significant differences between any of the groups on sEPSC
amplitude. In addition, there were no significant differences
between any of the groups on sIPSC amplitude or frequency.
Discussion
The purpose of the present study was to examine the interaction
between APOE genotype and the long-term loss of circulating
ovarian hormones on spine density and functional activity in the
hippocampus and amygdala from female human APOE TR mice.
The data presented herein revealed significant regionally specific
genotype-dependent effects in ovariectomized mice, with apoE4
mice displaying an overall increase in excitatory neurotransmis-
sion. In the hippocampus, OVX resulted in a significant increase
Figure 2. Ovariectomy differentially influences CA1 hippocampal synaptic transmission in female apoE TR mice. Input-output curves
presenting fEPSP slope in response to increasing stimulus input in apoE3 (A) and apoE4 (B) sham and OVX mice. (C) Average I/O slopes measured
between 1 mA and 150 mA resulted in a significant increase in I/O slope in apoE4 OVX mice relative to sham (p= 0.0033). Long-term potentiation
expressed as percent fEPSP slope normalized to baseline in apoE3 (D) and apoE4 (E) sham and OVX mice. Inset: representative traces of fEPSPs 5 min.
before (gray line), and 40 min. after (black line) LTP induction from the designated mice. (F) Summarized magnitude of LTP representing the average
percent potentiation of the last 20 minutes of recording. A two-way ANOVA resulted in a significant main effect of surgery (F1,38 = 8.04, p,0.0073)
and post-hoc tests revealed a significant reduction in LTP magnitude in apoE3 OVX mice relative to sham (*p = 0.019). Data are presented as mean 6
SEM from 1–2 slices recorded from the following number of mice: apoE3 sham n= 6; apoE3 OVX n= 8; apoE4 sham n= 7; apoE4 OVX n= 7.
doi:10.1371/journal.pone.0094071.g002
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in the level of basal synaptic transmission in apoE4 mice. OVX
also had a genotype-dependent effect in the lateral amygdala,
resulting in increased spine density and spontaneous excitatory
activity only in apoE4 OVX mice relative to sham. This is the first
study that has demonstrated that there is a significant change in
synaptic transmission in response to hormone loss in the human
APOE TR mice. These findings may help explain why human
APOE4 females with AD fail to benefit from hormone replacement
therapy [28,29].
As expected, there were no significant genotype differences
within sham-operated mice on any of the outcome measures.
These findings are consistent with previous studies showing 1) a
lack of genotype effect on CA1 hippocampal spine density in adult
(7–8 months) female apoE TR mice [13], 2) a lack of differences
between apoE3 and apoE4 on LTP in the dentate gyrus among
aged (18–24 months) female mice [40] and 3) a lack of differences
between apoE3 and apoE4 on NMDA-independent LTP in the
CA1 region in male mice [41].
We initially expected that apoE4 mice would have a more
severe decline in synaptic integrity compared to apoE3 mice in
response to OVX due to the protective actions of estrogen.
However, based on our results, it appears that apoE3 and apoE4
mice respond in opposing ways to ovarian hormone loss. It may be
that apoE3 mice are more susceptible to the effects of estrogen loss
and that apoE4 mice are more susceptible to the effects of
progesterone loss or the combined effects of both hormones. Both
estrogen and progesterone regulate neuronal morphology and
function via opposing mechanisms where the effect of estrogen has
largely been associated with an increase in neural excitability while
the effects of progesterone regulate inhibitory tone. In the
hippocampus, estrogen increases CA1 spine density [42,43] and
long-term potentiation [44]. In contrast, estrogen has been shown
to reduce excitability in the amygdala by decreasing excitatory
post-synaptic potentials in the basolateral amygdala [45] and by
reducing excitatory afferent connections to the medial amygdala
[46]. Therefore, apoE3 mice may be sensitive to estrogen loss
which leads to a decrease in spine density and thus a reduction in
hippocampal LTP while apoE4 mice may be more sensitive to the
combined loss of estrogen and progesterone, thus leading to and
increase in spine density and greater excitability in the amygdala.
Due to the lack of increase in spine density in the hippocampus,
future studies are warranted to explore whether the apoE4-
associated increase in hippocampal excitability is due to an
increase in post-synaptic AMPA receptor expression or an increase
in presynaptic inputs.
It is also possible that the loss of estrogen and/or progesterone
in apoE4 mice leads to hyperexcitablity via an enhanced response
to stressful stimuli. Synaptic plasticity in the amygdala has been
associated with increased susceptibility to stress [47]. For example,
immobilization stress leads to an increase in spine density in the
basolateral amygdala [48,49]. Our observed increase in total spine
density in apoE4 OVX mice is consistent with this effect. Further,
the significant changes in filopodia and thin spine type densities
are consistent with the formation of new dendritic spines as well as
the types of spines present when estrogen levels are low [20].
Interestingly, the hyperexcitability observed in apoE4 OVX
mice is consistent with a recent report showing increased seizure
phenotype in aged female apoE4 TR mice [50]. In addition,
rodent models have shown that excess hippocampal activation
contributes to age-related memory impairments [51,52] and that
treatment with low doses of antiepileptic drugs improved memory
performance [53,54]. Behavioral deficits due to impairments in
hilar GABAergic interneuron function have also been shown in
apoE4 females as a function of age [55]. While our results did not
show any effect of OVX on inhibitory activity in the amygdala, it
remains to be determined how GABAergic tone in the
hippocampus is modulated. Future studies involving the reintro-
duction of each hormone and combinations thereof are necessary
to further understand the complex interaction between apoE and
ovarian hormones on neuronal excitability and inhibition.
Another potential explanation for the differential apoE3 and
apoE4 finding may be due to de novo estrogen synthesis. Previous
studies have shown positive correlations between circulating
estradiol and spine density in CA1 apical dendrites [56,57].
Recent evidence suggests, however, that estrogen is synthesized in
select brain regions [58] even following OVX [59]. Studies have
shown the presence of aromatase, the final enzyme in the estrogen
synthesis pathway, in a population of CA1 pyramidal cells of OVX
female rhesus monkeys both with and without long-term cyclic
estradiol treatment [60]. Furthermore, inhibition of aromatase in
Figure 3. Ovariectomy increases lateral amygdala spine
density in female apoE4 TR mice. (A) Representative photomicro-
graphs of Golgi-stained lateral amygdala neurons from an adult female
apoE4 TR mouse brain using a 2.5X, 20X and (B) dendritic segments
from the designated cohorts using a 100X objective (scale bar is 5 mm).
(C) A two-way ANOVA of average total spine density resulted in a
significant interaction (F1,105 = 4.740, p = .0317) and post-hoc tests
revealed a significant increase in spine density in apoE4 OVX mice
relative to sham (p= 0.0038). Data represent the mean spine density 6
SEM from 8 dendritic segments per mouse, with N= 4 mice for each
group, except for apoE3 OVX mice, N = 3.
doi:10.1371/journal.pone.0094071.g003
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the brain decreases spine density in the hippocampus, suggesting
that it may be neural estradiol that affects synaptic integrity [56].
This could explain the unexpected result, if OVX did not in fact
have the expected effect on brain estrogen levels in apoE4 mice.
Future studies are warranted to determine if there are genotype
differences associated with aromatase activity and brain estradiol
levels in the APOE TR mice.
A third explanation for the differential result may be due to the
differences in estrogen receptor (ER) subtype localization. Estra-
diol action is mediated by two distinct receptors: ERa and ERb.
While both receptor subtypes are present in several regions of the
brain, ERa may be the predominant type in the hippocampus
whereas ERb is localized to nuclei within the amygdala [61]. Since
apoE4 has been hypothesized to have a dominant negative effect
on neurodegeneration [62], differences in the interaction between
estrogen receptors and apoE expression may account for
differences seen in the two regions. For example, it has been
demonstrated that activation of ERa increases apoE protein
expression, whereas activation of ERb decreases apoE expression
[25]. Thus, the inhibitory actions of estrogen on apoE expression
via ERb activation in the amygdala, and the loss of apoE
expression via activation of ERa in the hippocampus may be
beneficial against the negative effects on synaptic integrity
associated with apoE4. This hypothesis, too, would be useful to
evaluate in future studies by quantifying regional apoE levels in
response to the hormonal environment.
Finally, while the present study focused on the interaction
between apoE and estrogen in a female mouse model, the effects of
androgens and androgen receptors may also play a role in the
genotype specific outcomes. For example, it has been shown that
testosterone treatment is protective against apoE4-associated
deficits on a spatial learning and memory task in females and
this effect may be partially mediated by conversion to 17b-
estradiol since dihydrotestosterone was less efficacious than
testosterone [63]. Androgens mediate their effects by binding to
ARs [64,65] and it has been hypothesized that apoE4 may disrupt
androgen and AR-mediated pathways due to a stronger interac-
tion between apoE4 with AR, leading to a loss of AR signaling/
function [66]. In this case, the increase in synaptic plasticity we
observe in the OVX apoE4 mice may be due to a decrease in
apoE levels following OVX, leading to a decrease in apoE4-AR
interaction and thus an increase in AR signaling. This would
account for the genotype differences we observe, where the effects
depend on not only estrogen, but testosterone as well.
In conclusion, results from this study suggest that the presence
of circulating ovarian hormones plays a significant role in
modulating synaptic transmission on the basis of APOE genotype.
Importantly, the long-term loss of ovarian hormones varies
significantly depending on genotype and brain region, where the
CA1 region of the hippocampus is affected in apoE3 mice and the
lateral amygdala in apoE4 mice. Future studies aimed at
examining the effects of reintroduction of estrogens and/or
progesterone are warranted in order to identify the specific
hormones and time-course involved in these outcomes. Further
understanding how ovarian hormones differentially impact the
neurocircuitry of memory and emotion by APOE genotype is
critical toward developing effective treatments for age-related
neuronal dysfunction among postmenopausal women.
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